← All trials
NCT04124198
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2019
- Primary completion
- Jan 31, 2024
- Completion date
- Jan 31, 2029
- First posted
- —
- Last posted
- —
- Enrollment
- 138
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of CopenhagenLead sponsor
- Aarhus UniversityCollaborator
- University of Southern DenmarkCollaborator
- University of CopenhagenSponsor investigator
- Naestved HospitalCollaborator
- University of CopenhagenOverall official - principal investigator
- University of CopenhagenStudy chair
Drugs studied
Indications studied
- Squamous Cell Carcinoma of Head and Neck
- Carcinoma
- Carcinoma, Squamous Cell
- DNA Virus Infections
- Head and Neck Neoplasms
- Neoplasm Metastasis
- Neoplasms by Histologic Type
- Neoplasms by Site
- Neoplasms, Glandular and Epithelial
- Oropharyngeal Neoplasms
- Otorhinolaryngologic Diseases
- Otorhinolaryngologic Neoplasms
- Pharyngeal Diseases
- Quality of Life
- Tumor Virus Infections
- Virus Diseases
- Neoplasms, Squamous Cell
- Papillomavirus Infections
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.